Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Techbio / Proteomics
- Funding URL
- View Funding Page
Company Info
- Traction
- The startup aims to capture up to 50% of the global protein characterization market worth USD 21bn, with an annual growth rate of 16%. It works with customers in life science R&D, clinical & diagnostic, and food & beverage sectors.
- Founders
- Dr. Til Schlotter, Dr. Julian Hengsteler, Dr. Julia Wagner
- Company Description
- ETH techbio spin-off UNOMR is developing a novel single-molecule protein analysis technology to address limitations in current proteomics tools. The company aims to make high-resolution protein modification analysis broadly accessible across healthcare, pharmaceutical R&D, and food science.
- Market
- Healthcare, Pharmaceutical R&D, Food Science
- Location
-
Switzerland
Links